Neurodevelopmental outcomes in very low birth weight infants using aminophylline for the treatment of apnea

Pediatrics and Neonatology

Volumn 57, Issue 1, 2016, Pages 41-46

  Tey, Shu Leei ^a,b   Lee, Wei Te ^a   Lee, Pei Lun ^a   Lu, Chu Chong ^a   Chen, Hsiu Lin ^a,c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

aminophylline; Bayley scale; neurological outcomes

Indexed keywords

AMINOPHYLLINE; METHYLXANTHINE;

ADULT; ARTICLE; BAYLEY SCALES OF INFANT DEVELOPMENT; BRAIN DEVELOPMENT; BRAIN INJURY; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; GROUPS BY AGE; HUMAN; INFANT; LOADING DRUG DOSE; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NECROTIZING ENTEROCOLITIS; NEWBORN APNEA; NEWBORN INTENSIVE CARE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; VERY LOW BIRTH WEIGHT; APNEA; BRAIN; CHILD; CHILD DEVELOPMENT; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; NEWBORN; PHYSIOLOGY; PREMATURITY;

ADULT; AMINOPHYLLINE; APNEA; BRAIN; CHILD; CHILD DEVELOPMENT; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MALE; RETROSPECTIVE STUDIES;

EID: 84957428197     PISSN: 18759572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pedneo.2015.03.013     Document Type: Article

References (30)

1. N.N. Finer, R. Higgins, J. Kattwinkel, and R.J. Martin Summary proceedings from the apnea of prematurity group Pediatrics 117 2006 S47 51
2. G.H. Orozco, R.D. Mota, D. Villanueva, J.H. Bonilla, B.X. Suarez, and G.L. Torres Caffeine therapy for apnea of prematurity: pharmacological treatment Afr J Pharm Pharmacol 5 2011 564 571
3. A.D. McCallum, and T. Duke Evidence behind the WHO guidelines: hospital care for children: is caffeine useful in the prevention of apnoea of prematurity? J Trop Pediatr 53 2007 76 77
4. A. Janvier, M. Khairy, A. Kokkotis, C. Cormier, D. Messmer, and K.J. Barrington Apnea is associated with neurodevelopmental impairment in very low birth weight infants J Perinatol 24 2004 763 768
5. J. Zhao, F. Gonzalez, and D. Mu Apnea of prematurity: from cause to treatment Eur J Pediatr 170 2011 1097 1105
6. J. Cai, C.M. Tuong, Y. Zhang, C.B. Shields, G. Guo, H. Fu, and et al. Mouse intermittent hypoxia mimicking apnoea of prematurity: effects on myelinogenesis and axonal maturation J Pathol 226 2012 495 508
7. B.B. Fredholm Astra award lecture. Adenosine, adenosine receptors and the actions of caffeine Pharmacol Toxicol 76 1995 93 101
8. J.H. Thurston, R.E. Hauhard, and J.A. Dirgo Aminophylline increases cerebral metabolic rate and decreases anoxic survival in young mice Science 201 1978 649 651
9. R.G. Boutilier Mechanisms of cell survival in hypoxia and hypothermia J Exp Biol 204 2001 3171 3181
10. T.V. Dunwiddie, and S.A. Masino The role and regulation of adenosine in the central nervous system Annu Rev Neurosci 24 2001 31 55
11. C.E. Müller, and K.A. Jacobson Xanthines as adenosine receptor antagonists Handb Exp Pharmacol 200 2011 151 199
12. B. Schimidt, P.J. Anderson, L.W. Doyle, D. Dewey, R.E. Grunau, E.V. Asztalos, and et al. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity JAMA 307 2012 275 282
13. B. Schmidt, R.S. Roberts, P. Davis, L.W. Doyle, K.J. Barrington, A. Ohlsson, and et al. Caffeine therapy for apnea of prematurity N Engl J Med 354 2006 2112 2121
14. B. Schmidt, R.S. Roberts, P. Davis, L.W. Doyle, K.J. Barrington, A. Ohlsson, and et al. Long-term effects of caffeine therapy for apnea of prematurity N Engl J Med 357 2007 1893 1902
15. T.L. Gomella, M.D. Cunningham, and F.G. Eyal Neonatology: Management, procedures, on-call problems, diseases, and drugs 6th ed Chapter 132 Commonly Used Medications 2009 McGraw-Hill United States of America 732
16. N. Bayley Bayley scales of infant development 2nd ed. 1992 Psychological Corporation Texas
17. L.A. Papile, J. Burstein, R. Burstein, and H. Koffler Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weight less than 1500 gm J Pediatr 92 1978 529 534
18. R.A. Ehrenkranz, M.C. Walsh, B.R. Vohr, A.H. Jobe, L.L. Wright, A.A. Fanaroff, and et al. Validation of the national institutes of health consensus definition of bronchopulmonary dysplasia Pediatrics 116 2005 1353 1360
19. A.T. Shennan, M.S. Dunn, A. Ohlsson, K. Lennox, and E.M. Hoskins Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period Pediatrics 82 1988 527 532
20. M.J. Bell, J.L. Ternberg, R.D. Feigin, J.P. Keating, R. Marshall, L. Barton, and et al. Neonatal necrotizing enterocolitis. Therapeutic decision based upon clinical staging Ann Surg 187 1978 1 7
21. P.G. Davis, L.W. Doyle, A.L. Rickards, E.A. Kelly, G.W. Ford, N.M. Davis, and et al. Methylxanthines and sensorineural outcome at 14 years in children <1501g birthweight J Paediatr Child Health 36 2000 47 50
22. E. Ghods, A. Kreissl, S. Brandstetter, R. Fuiko, and K. Widhalm Head circumference catch-up growth among preterm very low birth weight infants: effect on neurodevelopmental outcome J Perinal Med 39 2011 579 586
23. A.L. Coates, H. Bergsteinsson, K. Desmond, E.W. Outerbridge, and P.H. Beaudry Long-term pulmonary sequelae of premature birth with and without idiopathic respiratory distress syndrome J Pediatr 90 1977 611 616
24. H. He, F. Chen, W. Ni, J. Li, and Y. Zhang Theophylline improves lipopolysaccharide-induced alveolarization arrest through inflammatory regulation Mol Med Rep 10 2014 269 275
25. A.R. Rooklin, A.S. Moomjian, J.G. Shutack, J.G. Schwartz, and W.W. Fox Theophylline therapy in bronchopulmonary dysplasia J Pediatr 95 1979 882 888
26. K. Schoen, T. Yu, C. Stockmann, M.G. Spigarelli, and C.M. Sherwin Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity Paediatr Drugs 16 2014 169 177
27. N. Jesse, and J. Neu Necrotizing enterocolitis: relationship to innate immunity, clinical features, and strategies for prevention Neo Reviews 7 2006 e143-e150
28. P.T. Nowicki, and W. Oh Methylxanthines and necrotizing enterocolitis revisited J Pediatr Gastroenterol Nutr 9 1989 137 138
29. A. Erenberg, R.D. Leff, D.G. Haack, K.W. Mosdell, G.M. Hicks, and B.A. Wynne Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study Pharmacotherapy 20 2000 644 652
30. C.H. Blauw-Hospers, and M. Hadders-Algra A systematic review of the effects of early intervention on motor development Dev Med Child Neurol 47 2005 421 432